ArticleBioinformatics advances2026
MIRit: an integrative R framework for the identification of impaired miRNA-mRNA regulatory networks in complex diseases.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Small RNA sequencing of human sural nerves identifies widespread microRNA dysregulation and Schwann cell-localized miR-21-5p in diabetic peripheral neuropathy.bioRxiv : the preprint server for biology · 2026Article
- Bioinformatic prediction, qCLASH, and AlphaFold3 reveal non-overlapping layers of the miR-214-3p-mRNA interactome.Frontiers in genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: MicroRNAs (miRNAs) play a central role in controlling gene expression, and their abnormal activity is frequently linked to disease. Despite advancements in transcriptomic technologies, elucidating miRNA-mediated mechanisms remains challenging due to methodological limitations and a lack of standardized frameworks. Results: To overcome these barriers, we developed MIRit, a comprehensive R package designed for the rigorous analysis of miRNA-mRNA interactions. With flexible support for both matched and unmatched datasets, MIRit leverages cutting-edge target identification strategies and applies suitable statistical approaches for each scenario. In this study, we benchmarked the performance of commonly used statistical tests for integrative miRNA analysis and demonstrated the effectiveness of MIRit across three human disease contexts-dilated cardiomyopathy, clear cell renal cell carcinoma, and Alzheimer's disease-by uncovering functionally relevant miRNA-target disruptions consistent with known disease mechanisms. Through its streamlined pipeline and biologically appropriate methods, MIRit enables more reproducible and accurate insights into the complex landscape of post-transcriptional regulation. Availability and implementation: The tool is fully open-source and freely accessible via Bioconductor (https://bioconductor.org/packages/release/bioc/html/MIRit.html), making it readily available to the broader scientific community.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.